Telehealth Delivery (Tele-B6)

Status Recruiting

Clinical Trial Summary

The research team has developed an interventional group program for young men living with HIV and will be adapting it for telehealth delivery. The purpose of the study is to determine whether or not this program can help improve social connections and the health of young men in online delivery and evaluate its potential for implementation in a community setting. The study has three phases: (1) engaging a community advisory board to create and adapt the intervention for online delivery, (2) a randomized clinical trial of the online intervention, and (3) evaluation of the program for community implementation with our partner organization. Participants in the second phase of the study will meet with a study team member to discuss the research process and provide informed consent. The community organization employees will provide consent online prior to completion of a survey and indicate whether they consent to be contacted further for in-depth interviews.

Clinical Trial Description

Subjects will participate in synchronous, online discussion sessions via videoconference for two hours per week over a six-week period. Sessions will include engaging educational components and interactive activities including discussions of case scenarios and sharing of personal experiences where desired. At the end of each videoconference session, participants will be asked to complete a brief session evaluation form in which they will rate the content, facilitation, and overall experience for the week. The long-term goal is to improve engagement across the HIV continuum of care (HIV-CoC) by enhancing individual- and community-level resilience processes among young Black gay, bisexual and other men who have sex with men (YB-GBMSM) living with HIV. To this end, the research team has used community-based participatory research methods to develop Brothers Building Brothers by Breaking Barriers (B6), a novel group-level intervention designed to affirm intersectional identities and augment social capital among YB-GBMSM. The goal of this current study is to adapt and pilot B6 for telehealth delivery (creating tele-B6) within the context of an established community-based organization (CBO), as a strategy for enhancing feasibility and scalability prior to a larger efficacy trial. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05829759
Study type	Interventional
Source	Emory University
Contact	Sophia A. Hussen, MD, MPH
Phone	(404) 616-2440
Email	shussen@emory.edu
Status	Recruiting
Phase	N/A
Start date	April 18, 2023
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03661203` - Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM
Completed	`NCT00381212` - A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.	Phase 1/Phase 2
Not yet recruiting	`NCT05983536` - The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
Recruiting	`NCT04832477` - Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US	N/A
Active, not recruiting	`NCT04044586` - HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)
Completed	`NCT03218839` - Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males	N/A
Active, not recruiting	`NCT00797030` - Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus	Phase 4
Recruiting	`NCT04088916` - Proviral DNA as a Target for HIV-1 Resistance Analysis
Completed	`NCT03367130` - Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal	N/A
Completed	`NCT04849767` - National Survey About Trajectory and Life Conditions of HIV Trans People in France
Completed	`NCT05674682` - Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study	N/A
Recruiting	`NCT05174234` - Precariousness and Sexual Vulnerability of People From Haiti Living With or Without HIV in French Guiana
Completed	`NCT00130819` - Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants	Phase 2
Active, not recruiting	`NCT04706624` - Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics	N/A
Recruiting	`NCT03858478` - Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST	Phase 4
Completed	`NCT02154971` - Assessment of Age-related Hearing Loss in HIV-1 Patients
Recruiting	`NCT03333083` - Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen	Phase 3
Recruiting	`NCT03311945` - Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM	Phase 3
Recruiting	`NCT03795415` - ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali
Completed	`NCT01813292` - Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine	N/A